why choose us

First received: August 18, 2023

Clinical Trial: Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Retroperitoneal Sarcoma

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for High-Risk Adipocytic Retroperitoneal Sarcomas

Brief Summary: This phase I trial tests the safety, side effects, and best dose of abemaciclib and how well it works with radiation therapy before surgery in treating patients with high-risk adipocytic retroperitoneal sarcoma.Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors.Giving abemaciclib together with radiation therapy before surgery may shrink tumors in patients with high-risk adipocytic…

Read more